Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,304
Out of 5,124 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $125.29 | -4.22% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $85.25 | +52.49% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $74.49 | +47.67% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.87 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $66.37 | -52.92% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $32.73 | +6.94% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $122.04 | +141.72% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $61.53 | +47.91% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $66.55 | -59.43% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $284.24 | -76.43% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $125.29
Upside: -4.22%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $85.25
Upside: +52.49%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $74.49
Upside: +47.67%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.87
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $66.37
Upside: -52.92%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $32.73
Upside: +6.94%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $122.04
Upside: +141.72%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $61.53
Upside: +47.91%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $66.55
Upside: -59.43%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $284.24
Upside: -76.43%